Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There was also a significant statistical difference between study groups as regards AST and ALT (p < 0.052 and p < 0.027, respectively), in addition to a highly significant statistical difference among study groups as regards vitamin D levels (p < 0.001), where a significant decline in mean vitamin D levels was noticed in ICU patients compared to ward patients (18.3 ± 4.8 vs 23.1 ± 3.9) (Table 2).Comparison between study groups as regards different laboratory parametersAdmissiont-testWardICUtpTLCRange2.3 to 20.83.3 to 33 − 2.9220.005Mean ± SD7.650 ± 4.49112.520 ± 7.948LymphocytesRange0.3 to 20.2 to 1.70.8220.415Mean ± SD0.750 ± 0.4320.657 ± 0.448NeutrophilsRange1: 182.2 to 31.9 − 2.9810.004Mean ± SD6.303 ± 4.26111.050 ± 7.610HemoglobinRange6.5 to 18.57 to 180.3340.739Mean ± SD12.320 ± 2.62112.110 ± 2.229PlateletsRange17: 515112 to 398 − 0.4120.682Mean ± SD200.433 ± 91.409209.267 ± 73.555Neutrophil-lymphocyte ratioRange1: 432 to 106 − 2.4980.015Mean ± SD12.967 ± 13.33025.567 ± 24.196CRPRange0.1 to 3004.5 to 330 − 2.0190.048Mean ± SD47.049 ± 70.47092.331 ± 100.650ESRRange5.1 to 1202 to 300 − 2.2420.029Mean ± SD30.617 ± 32.17462.190 ± 70.114CreatinineRange0.3 to 90.4 to 6.1 − 0.6070.546Mean ± SD1.273 ± 1.5941.490 ± 1.132ASTRange9: 2154 to 212 − 1.9880.052Mean ± SD38.067 ± 41.04761.700 ± 50.545ALTRange9: 18513 to 338 − 2.2720.027Mean ± SD37.033 ± 35.76276.500 ± 88.160AlbuminRange1.8 to 3.92.1 to 4.21.5560.125Mean ± SD3.327 ± 0.4703.123 ± 0.540FerritinRange56: 125526.7 to 2100 − 2.5690.013Mean ± SD369.773 ± 302.147642.770 ± 497.362LDHRange110: 963125 to 986 − 2.0810.042Mean ± SD379.667 ± 256.082518.967 ± 262.309D-dimerRange0.2 to 2.90.212 to 6.9 − 3.3030.002Mean ± SD0.737 ± 0.7151.806 ± 1.621Vitamin DRange15: 307 to 274.310 < 0.001Mean ± SD23.133 ± 3.90218.267 ± 4.799p > 0.05: non-significant (NS); p < 0.05: significant (S); p < 0.001: highly significant (HS)

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This comparative cross-sectional study was conducted on 60 Egyptian COVID-19 patients (35 males (58.3%) and 25 females (41.7%), mean age: 59.2 ± 15.3 years) recruited from our institution’s quarantine field hospital and quarantine university hospital ICU and inpatient wards during the period from July to December 2021.

Source: Methods.

These patients were divided into two groups according to the severity of COVID-19 infection; the ICU group included 30 patients with severe COVID-19 infection who were admitted to ICU, while the Word group included 30 patients with moderate COVID-19 infection admitted to inpatient wards.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of serum zinc level and clinical outcome in Egyptian COVID-19 patients

Cross-sectional study · The Egyptian Journal of Internal Medicine · 2022

Original publication title

Association of serum zinc level and clinical outcome in Egyptian COVID-19 patients

Ahmed M. F. Mansour; Noha El Nakeeb; Norhan Khaled Mohamed Kamal; Ahmed Mohamed ElGhandour

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Low serum zinc level is associated with the severe outcome of COVID-19 infection.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Zinc is an anti-inflammatory and antioxidant micronutrient found in food. Due to its well-established role in immunity, it is currently being used in some clinical trials against coronavirus disease-2019 (COVID-19). This study aimed to assess the association between the mean serum zinc level in COVID-19 Egyptian patients and its relationship with disease severity. This cross-sectional study was conducted on sixty patients with confirmed COVID-19 infection. These patients were divided into two groups according to clinical outcome, group 1 which included 30 intensive care unit (ICU) patients and group 2 which included 30 patients who were admitted to the ward.

Mean serum levels of zinc were compared between the two groups.

Source: Background

Abstract: Results

There was a statistically significant difference noted among study groups regarding the serum zinc level (p < 0.039), where lower mean serum zinc levels were noted in ICU patients compared to ward patients (70.6 ± 5.7 vs 73.8 ± 6.1).

Source: Results

Abstract: Conclusion

Low serum zinc level is associated with the severe outcome of COVID-19 infection.

Source: Conclusion
Authors’ abstract

Background

Zinc is an anti-inflammatory and antioxidant micronutrient found in food. Due to its well-established role in immunity, it is currently being used in some clinical trials against coronavirus disease-2019 (COVID-19). This study aimed to assess the association between the mean serum zinc level in COVID-19 Egyptian patients and its relationship with disease severity. This cross-sectional study was conducted on sixty patients with confirmed COVID-19 infection. These patients were divided into two groups according to clinical outcome, group 1 which included 30 intensive care unit (ICU) patients and group 2 which included 30 patients who were admitted to the ward.

Mean serum levels of zinc were compared between the two groups.

Results

There was a statistically significant difference noted among study groups regarding the serum zinc level (p < 0.039), where lower mean serum zinc levels were noted in ICU patients compared to ward patients (70.6 ± 5.7 vs 73.8 ± 6.1).

Conclusion

Low serum zinc level is associated with the severe outcome of COVID-19 infection.

Publication and source details

Original title: Association of serum zinc level and clinical outcome in Egyptian COVID-19 patients

Ahmed M. F. Mansour; Noha El Nakeeb; Norhan Khaled Mohamed Kamal; Ahmed Mohamed ElGhandour

The Egyptian Journal of Internal Medicine · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T22:20:48.192708+00:00

DOI: 10.1186/s43162-022-00159-z · PMC9510454